X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - HEALTHTECHZONE.COM - IT Professionals - 12/Aug 12:30

CytoDyn Announces Completion of FDA Meeting on Phase II Study of Leronlimab in Patients with Relapsed/Refractory Microsatellite Stable Colorectal Cancer

Articles similaires

Sorry! Image not available at this time

Corvus Stock Up on Initiation of Phase III Lymphoma Study on Lead Drug

zacks.com - 14:47

CRVS stock gains 14% on initiating a registrational study on its lead candidate, soquelitinib, to treat relapsed/refractory peripheral T-cell...

Sorry! Image not available at this time

Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid

healthtechzone.com - 05/Sep 10:30

Sorry! Image not available at this time

Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid

healthtechzone.com - 05/Sep 10:30

Sorry! Image not available at this time

Arrowhead Pharmaceuticals Presents New Pivotal Phase 3 Data at ESC 2024 from PALISADE Study of Plozasiran in Patients with Familial Chylomicronemia Syndrome

drugs.com - 02/Sep 04:09

PASADENA, Calif.–(BUSINESS WIRE)–Sep. 2, 2024– Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced results from the Phase 3 PALISADE...

Sorry! Image not available at this time

Living in Rural Areas Tied to Lower Early-Onset Colorectal Cancer Survival

drugs.com - 30/Aug 22:43

FRIDAY, Aug. 30, 2024 -- Patients with early-onset colorectal cancer (EO-CRC) living in rural areas have lower five-year survival rates than their...

Sorry! Image not available at this time

Omitting 5-FU Bolus Does Not Reduce Survival in Advanced Cancer

drugs.com - 10/Sep 22:20

TUESDAY, Sept. 10, 2024 -- Omission of 5-fluorouracil (5-FU) from the first-line FOLFOX, FOLFIRI, and FOLFIRINOX regimens is not associated with...

Sorry! Image not available at this time

Bayer Initiates Late-Stage Study on Investigational NSCLC Drug

zacks.com - 30/Aug 17:31

BAYRY enrolls the first patient in the phase III SOHO-02 study among treatment-na??ve patients with advanced NSCLC with HER2-activating mutations.

Sorry! Image not available at this time

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

drugs.com - 03/Sep 01:09

LOS ALTOS, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing...

Sorry! Image not available at this time

Lung Function Stable Three Years After Hematopoietic Cell Transplant in Sickle Cell

drugs.com - 05/Sep 14:09

THURSDAY, Sept. 5, 2024 -- Lung function remains stable over three years after hematopoietic cell transplant (HCT) among patients with sickle cell...

Sorry! Image not available at this time

Psychological Illness, CVD Risk Increased for Relatives, Spouses of Cancer Patients

drugs.com - 09/Sep 16:02

MONDAY, Sept. 9, 2024 -- Cancer diagnosis is associated with an increased risk for psychological illness and cardiovascular disease among...

Les derniers communiqués